No Fixed Pricing
IP licensing terms are negotiated per application. Every deal accounts for your manufacturing scale, regulatory pathway, and territorial requirements.
Learn about our process →Biotechnology IP Licensing — Edinburgh, Scotland
We Don't Sell Research.
We License Validated IP.
Proof-of-concept microbial strains, green nanoparticle protocols, and bioprocess formulations — ready for tech transfer under English law.
Scroll
The Licensing Model
Enterprise IP,
Not Shelf Products
NDA-Gated Disclosure
All technical data, strain characteristics, and performance metrics are shared only after mutual NDA execution. Your competitive intelligence is protected.
English Law Jurisdiction
All agreements are governed by English law. Disputes resolved in UK courts. Clear jurisdiction for international licensees.
IP Portfolio
Proof-of-Concept
Assets Ready for Transfer
Each asset package includes validation data, strain deposits, and provisional IP filings where applicable.
Engineered organisms with validated yield data, NCIMB/ATCC deposits. Includes full characterization reports and growth optimization protocols.
Request Data Sheet →Biosynthesis methods with documented size distribution and stability specifications. Environmentally friendly alternatives to chemical synthesis routes.
Request Data Sheet →pH and temperature-stable enzyme candidates with full activity curves and substrate specificity profiles. Ready for industrial process integration.
Request Data Sheet →PHA/PHB production strains with documented scale parameters and material property characterization. Biodegradable polymer precursors for packaging and medical applications.
Request Data Sheet →Natural product isolates with documented bioactivity profiles and preliminary IP landscape analysis. Promising leads for antimicrobial and therapeutic development.
Request Data Sheet →